Oral Delivery of Large Molecules

Investor

Overview

SEC Filing Details

Document Details

Form
4
Filing Date
Jan 11, 2022
Document Date
Jan 1, 2022
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Entera Bio Ltd.
Issuer
Entera Bio Ltd.
Filer
GARCEAU ROGER